KFP
GSK icon

KB Financial Partners’s GSK GSK Stock Holding History

KB Financial Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,539
Closed -$375K – 619
2023
Q1 		$375K Buy
10,539
+1,778
+20% +$62.2K 0.11% 118
2022
Q4 		$308K Sell
8,761
-1,014
-10% -$33.8K 0.11% 134
2022
Q3 		$288K Buy
9,775
+2,921
+43% +$111K 0.1% 136
2022
Q2 		$373K Buy
+6,854
New +$378K 0.13% 100
2022
Q1 		– Sell
-30
Closed -$2K – 629
2021
Q4 		$2K Buy
+30
New +$1.56K ﹤0.01% 589
2021
Q3 		– Sell
-2,962
Closed -$147K – 329
2021
Q2 		$147K Buy
+2,962
New +$142K 0.06% 182

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KB Financial Partners's GSK Position: Q2 2023 in Review

KB Financial Partners sold out of GSK (GSK) in Q2 2023, closing a stake of 10,539 shares — an estimated $375K sold.

KB Financial Partners first reported a position in GSK in Q2 2021 and held it in 6 quarters. The position peaked at $375K in Q1 2023. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • KB Financial Partners reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • KB Financial Partners sold 10,539 GSK shares in Q2 2023, an estimated $375K.
  • KB Financial Partners first reported a position in GSK in Q2 2021 and held it in 6 quarters.
  • KB Financial Partners's GSK position peaked at $375K in Q1 2023.
  • 827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on KB Financial Partners's 13F filing for Q2 2023, filed 15 Aug 2023.